Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Status:
Active, not recruiting
Trial end date:
2022-10-19
Target enrollment:
Participant gender:
Summary
This pilot phase I clinical trial studies how well lapatinib ditosylate before surgery works
in treating patients with high-grade glioma that has come back after a period of time during
which the tumor could not be detected. Lapatinib ditosylate may stop the growth of tumor
cells by blocking some of the enzymes needed for cell growth.